Company / Assets per Share
TG Therapeutics, Inc. Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$6.82
FY2025
5-year range
$1.35 / $6.82
FY2021-FY2025
Trend
+78.8%
vs FY2024
Sector context
#127 of 210
Health Care
What the data says
At $6.82, TG Therapeutics, Inc.'s assets per share ranks #127 of 210 in the Health Care sector. Assets per Share has increased for 3 consecutive years, from $1.35 in FY2022 to $6.82 in FY2025.
Based on SEC 10-K filings.
6.82 in FY2025 with a 5-year CAGR of +3.6%.
Improved from $2.25 to $6.82 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- +71.6%
- 5-Year CAGR
- +3.6%
- 10-Year CAGR
- -
Sector benchmark
#127 of 210 in Health CareTop 60% of 210This company $6.82 Sector average $353.15
▼
-98.1% below sector average
Key checks
Key Insights
- TG Therapeutics, Inc.'s assets per share has grown for 3 consecutive years.
- In FY2025, assets per share increased 78.8% year-over-year.
- Ranks #127 out of 210 companies in the Health Care sector.
- Lowest assets per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 1.05 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.82 | +78.8% |
| FY2024 | $3.82 | +69.4% |
| FY2023 | $2.25 | +66.6% |
| FY2022 | $1.35 | -50.0% |
| FY2021 | $2.70 | -52.8% |
| FY2020 | $5.72 | +194.3% |
| FY2019 | $1.94 | +70.0% |
| FY2018 | $1.14 | -27.1% |
| FY2017 | $1.57 | +40.5% |
| FY2016 | $1.12 | -55.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026